Led by La Fondazione Italiana Linfomi (FIL), a non-profit Italian professional lymphoma research organization, and supported by an unrestricted educational grant from Celgene Corporation, the Lymphoma Hub has been launched as a new online community for hematologists and oncologists treating lymphoma.
Guided by a Steering Committee of internationally recognized lymphoma experts, the Lymphoma Hub is a global network dedicated to providing a trusted online resource to improve knowledge and understanding of lymphoma. Its goal is to expedite learning through the sharing of expertise and to disseminate the latest news and information to healthcare professionals worldwide. The portal is optimized for multiple devices and platforms, with a fully responsive design making it easy to view on the go. The use of social media further supports users' easy access to the most current information in their field.
"I am very pleased to announce the birth of the Lymphoma Hub and to hold the role of coordinator of such a group of internationally recognized lymphoma experts, who are devoted to improving knowledge and understanding of lymphoma in healthcare professionals worldwide" said Professor Federico Massimo, President of FIL and Chair of the Lymphoma Hub Steering Committee.
Visit the Lymphoma Hub to find out more.
About the Lymphoma Hub
The Lymphoma Hub is a global network dedicated to providing a trusted online resource to improve knowledge and understanding of lymphoma. Its goal is to expedite learning through the sharing of expertise and to disseminate the latest news and information to healthcare professionals worldwide. Visit the Lymphoma Hub at http://www.lymphomahub.com.
About La Fondazione Italiana Linfomi
La Fondazione Italiana Linfomi (FIL) is a non-profit organization, which coordinates the activities carried out in Italy in the field of lymphoma by more than 120 centers located throughout the country. Founded in Alessandria on September 30, 2010, FIL encourages prospective and retrospective studies in order to answer important questions surrounding lymphoma. The aim of FIL is to raise awareness of lymphoma and help patients and relatives by coordinating research groups in the fight against lymphoma. For more information, please visit the organization's website at http://www.filinf.it.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's website at http://www.celgene.com.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.